It'll be an interesting few weeks I think.
- Short position has decreased but not substancially (6.43% to 5.96%) despite good stable price performance
- Price has held above 200 MA/SMA (daily) for the first time since August 2024 where it dropped from $19~
- Selling pressure still seems to be there (whether it is real or testing supply who knows)
- Seeing the random larger 'on screen' sell orders which aren't close to execution. We know most trading happens 'off screen'
- SBB has been strong but has only a few days left.
- Over 3 months the largest three buyers Jefferies (mostly SBB), Virtu ITG (automated traders/TA people), UBS securities
- Over 3 months the largest three sellers JP Morgan, Wilsons (overall a net buyer on a longer time frame), Merril Lynch
- Over 3 months largest volume UBS (no suprise) - they bought heavily on liberation day and the days folllowing
Prior to crossing the 200 SMA & EMA
On screen now (12/6) with the price at $13.83![]()
- Forums
- ASX - By Stock
- NEU
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$14.20

Share Price, page-15538
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.20 |
Change
0.000(0.00%) |
Mkt cap ! $1.761B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12 | $15.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.34 | 4 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 190 | 14.440 |
3 | 150 | 14.430 |
3 | 125 | 14.420 |
2 | 125 | 14.410 |
1 | 50 | 14.400 |
Price($) | Vol. | No. |
---|---|---|
14.480 | 55 | 1 |
14.500 | 6413 | 11 |
14.510 | 168 | 2 |
14.520 | 75 | 1 |
14.530 | 50 | 1 |
Last trade - 09.49am 30/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online